Frequent mutations of Ki-ras but no mutations of Ha-ras and p53 in lung lesions induced by N-nitrosobis(2-hydroxypropyl)amine in rats

Molecular Carcinogenesis

Volumn 15, Issue 4, 1996, Pages 276-283

  Kitada, Hiromichi ^a   Tsutsumi, Masahiro ^a   Tsujiuchi, Toshifumi ^a   Takahama, Makoto ^a   Fukuda, Tomokazu ^a   Narita, Nobuhiro ^a   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Ki ras; Lung carcinogenesis; Nitrosamine; p53; Rat

Indexed keywords

BIS(2 HYDROXYPROPYL)NITROSAMINE; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENE MUTATION; LUNG CARCINOGENESIS; MALE; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; PRIORITY JOURNAL; RAT;

ADENOCARCINOMA; ANIMALS; BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; DNA PRIMERS; GENES, P53; GENES, RAS; LUNG NEOPLASMS; MALE; MOLECULAR SEQUENCE DATA; MUTAGENS; MUTATION; NITROSAMINES; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS P21(RAS); RATS; RATS, WISTAR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029939411     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199604)15:4<276::AID-MC5>3.0.CO;2-E     Document Type: Article

References (38)

1. Kruger FW, Pour P, Althoff J. Induction of pancreatic tumors by Di-isopropanolnitrosamine. Die Naturwissenschaften 61:328-329, 1974.
2. Pour P, Krüger FW. A new approach for indication of pancreatic neoplasms Cancer Res 35:2259-2268, 1975
3. Pour P, Krüger FW, Althoff J, Cardesa A, Mohr U. Cancer of the pancreas induced in the Syrian golden hamster. Am J Pathol 76.349-358, 1974.
4. Konishi Y, Denda A, Kondo H, Takahashi S. Lung carcinomas induced by oral administration of N-bis(2-hydroxypropyl)nitrosamine in rats. Jpn J Cancer Res 67 773-780, 1976.
5. Pour P, Salmasi S, Runge R, et al. Carcinogenicity of N-nitrosobis(2-hydroxypropyl)amine and N-nitrosobis(2-oxopropyl)amine in MRC rats. J Natl Cancer Inst 63:181-190, 1979.
6. Liginsky W. Species differences in nitrosamine carcinogenesis. J Cancer Res Clin Oncol 108:46-55, 1984.
7. Konishi Y, Kondo H, Denda A, Takahashi S, Inui S Lung carcinomas induced by oral administration of N-bis(2-hydroxypropyl)nitrosamine in rats. In: Severi L (ed), Tumors of Early Life in Man and Animals, Perugia Quadrennial International Conference on Cancer. Division of Cancer Research, Perugia University, Perugia, 1978, pp. 637-649.
8. Mori Y, Yamazaki H, Yamamoto K, Nakajima A, Yokose Y, Konishi Y. Mutagenesis of isopropanolamine and ethanolamine after reaction with sodium nitrite. Exp Oncol (Life Sci Adv) 7:35-40, 1988
9. Konishi Y, Yokose Y, Mon Y, et al Lung carcinogenesis by N-nitrosobis(2-hydroxypropyl)amine-related compounds and their formation in rats. In: Bartsch H, O'Neill IK, Schulte-Hermann R (eds), Relevance of N-Nitroso Compound to Human Cancer. Exposure and Mechanism IARC Scientific Publication No. 84, International Agency for Research on Cancer, Lyon, France, 1987, pp 250-252
10. Yamamoto K, Eimoto H, Takashima Y, et al Initiation activity of endogenous synthesized N-nitrosobis(2-hydroxypropyl)amine in the rat liver. Cancer Lett 45:221-225, 1989.
11. Fearon ER, Vogelstein B A genetic model for colorectal tumori-genesis. Cell 61:759-767, 1990.
12. Bos JL The ras gene family and human caranogenesis Mutat Res 195 255-271, 1988.
13. Barbacid M. ras genes. Annu Rev Biochem 56 779-827, 1987
14. Rodenhuis S, Slebos RJC. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res 52:2665s-2669s, 1992.
15. Sugio K, Kishimoto Y, Virmani AK, et al Ki-ras mutations are a relatively late event in the pathogenesis of lung carcinomas Cancer Res 54:5811-5815, 1994.
16. Zhi-Hua Li, Zheng J, Weiss LM, Shibata D. c-Ki-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am J Pathol 144:303-309, 1994.
17. Ohgaki H, Furukawa F, Takahashi M, Kleihues P. Ki-ras mutations are frequent in pulmonary squamous cell carcinomas but not in adenocarcinomas of WBN/Kob rats induced by N-nitrosobis(2-oxopropyl)amine. Carcinogenesis 14 1471-1473, 1993.
18. Stegelmeier BL, Gillett NA, Rebar AH, Kelly G. The molecular progression of plutonium-239-induced rat lung carcinogenesis: Ki-ras expression and activation Mol Caronog 4.43-51, 1991
19. Nickeli-Brady C, Hahn FF, Finch GL, Belinsky SA. Analysis of Kiras, p53 and c-raf-1 mutations in beryllium-induced rat lung tumors. Carcinogenesis 15.257-262, 1994.
20. Swafford DS, Nikula KJ, Mitchell CE, Belinsky SA. Low frequency of alterations in p53, Ki-ras, and mdm2 in rat lung neoplasms induced by diesel exhaust or carbon black. Carcinogenesis 16.1215-1221, 1995
21. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4378, 1994
22. Tsutsumi M, Kondoh S, Noguchi O, et al. Ki-res gene mutation in early ductal lesions induced in a rapid production model for pancreatic carcinomas in Syrian hamsters. Jpn J Cancer Res 84.1101-1105, 1993.
23. Orita M, Iwahara H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single strand conformation polymorphisms. Proc Natl Acad Sci USA 86:2766-2770, 1989.
24. Orita M, Suzuki Y, Sekiya T, Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics 5:874-879, 1989.
25. Murakami Y, Hayashi K, Sekiya T. Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis Cancer Res 51:3356-3361, 1991
26. Tsutsumi M, Murakami Y, Kondoh S, et al. Comparison of Ki-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine. Jpn J Cancer Res 84 956-960, 1993.
27. Makino H, Ishizaka Y, Tsujimoto A, et al Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Proc Natl Acad Sci USA 89 4850-4854, 1992.
28. Mori Y, Niwa T, Takahashi H, et al Mutagenicity of N-nitrosobis(2-hydroxypropyl)amine and its related compounds in the presence of rat lung and liver S9. Cancer Lett 18:271-275, 1983
29. Yokose Y, Yamamoto K, Nakazima A, et al Carcinogenic potency of N-nitrosomethyl(2-hydroxypropyl)amine and other metabolic relatives of N-nitrosobis(2-hydroxypropyi)amine by single intrapentoneal injection of the lung of rats. Jpn J Cancer Res 79:698-704, 1988
30. Stowers SJ, Glover PL, Reynolds SH, Boone LR, Maronpot RR, Anderson MW. Activation of the Ki-ras protooncogene in lung tumors from rats and mice chronically exposed to tetranitromethane. Cancer Res 47.3212-3219, 1987.
31. Belinsky SA, Devereux TR, Foley JF, Maronpot RR, Anderson MW Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyndyl)1 -butanone in the A/J mouse. Cancer Res 52:3164-3173, 1992
32. You M, Wang Y, Lineen AM, Gunning WT, Stoner GD, Anderson MW. Mutagenesis of the Ki-ras protooncogene in mouse lung tumors induced by N-ethyl-N-nitrosourea or N-nitrosodiethylamine Carcinogenesis 13:583-1586, 1992
33. Kraegel SA, Gumerlock PH, Dungworth DL, Oreffo VIC, Madewell BR. Ki-ras activation in non-small cell lung cancer in the dog. Cancer Res 52 4724-4727, 1992.
34. Westra WH, Slebos RJC, Offerhaus GJA, et al. Ki-ras oncogene activation in lung adenocarcinomas from former smokers Cancer 72:432-438, 1993.
35. Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG, van Zandwijk N, Bos JL Mutational activation of the Ki-ras oncogene: A possible pathogenetic factor in adenocarcinoma of the lung. N Engl J Med 317 929-935, 1987
36. Rodenhuis S, Slebos RJC, Boot AJM, et al. Incidence and possible clinical significance of Ki-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res 48:5738-5741, 1988.
37. Sozzi G, Miozzo M, Donghi R, et al. Deletions of 17p and p53 mutations in preneoplastic lesions of the lung Cancer Res 52.6079-6082, 1992.
38. Vähäkangas KH, Samet JM, Metcaif RA, et al. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet 339:576-580, 1992.